3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. - Haregewein Assefa; Shantaram Kamath; John K. Buolamwini (J. Comput. Aided Mol. Des., 2003)